ASX:HMD

HeraMED (HMD) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
98,572 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HMD stock logo

About HeraMED Stock (ASX:HMD)

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.

HMD Stock News Headlines

READ THIS – If You Missed Out On The AI Boom
Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”
HeraMED Limited (HMD.AX)
READ THIS – If You Missed Out On The AI Boom
Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”
HeraMED Limited
See More Headlines
Receive HMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HeraMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-4,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$205,434.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.13
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Ronald Peter Weinberger AIMM
    BSc (Hons), Ph.D., Executive Chairman
  • Mr. Ido Toronchik (Age 41)
    Chief Financial Officer
  • Henry Jordan
    Head of Investor Relations
  • Mr. Ariel Laden
    Vice President of Marketing
  • Mr. Keith Koby BSEET
    MBA, President of North America
  • Mr. Jonathan Hart B.Com. (Age 40)
    L.L.B., Company Secretary

This page (ASX:HMD) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners